(Q45096984)

9 December 2017

title

A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis (English)

1 reference

9 December 2017

1 reference

1 reference

5

Thomas J Walsh

1 reference

9 December 2017

David S Krause

1

1 reference

9 December 2017

A E Simjee

2

1 reference

9 December 2017

Christo van Rensburg

3

1 reference

9 December 2017

Johann Viljoen

4

1 reference

9 December 2017

Beth P Goldstein

6

1 reference

9 December 2017

Michele Wible

7

1 reference

9 December 2017

Timothy Henkel

8

1 reference

9 December 2017

language of work or name

English

0 references

publication date

27 August 2004

1 reference

Clinical Infectious Diseases

9 December 2017

published in

1 reference

9 December 2017

volume

39

1 reference

9 December 2017

issue

6

1 reference

9 December 2017

page(s)

770-775

1 reference

Natural history of opportunistic disease in an HIV-infected urban clinical cohort

9 December 2017

cites work

1 reference

Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy

21 January 2018

1 reference

21 January 2018

1 reference

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

21 January 2018

1 reference

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

21 January 2018

1 reference

Therapeutic options for the management of oropharyngeal and esophageal candidiasis in HIV/AIDS patients

21 January 2018

1 reference

In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species

21 January 2018

1 reference

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

21 January 2018

1 reference

In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients

21 January 2018

1 reference

Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B.

21 January 2018

1 reference

In vitro susceptibility of Candida dubliniensis to current and new antifungal agents

21 January 2018

1 reference

Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis

21 January 2018

1 reference

Pneumococcal aortitis, report of a case with emphasis on the contribution to diagnosis of positron emission tomography using fluorinated deoxyglucose

21 January 2018

1 reference

A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/423378

1 reference

9 December 2017

1 reference